1895 related articles for article (PubMed ID: 21979600)
21. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
22. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
23. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases.
Gilks CB; Clement PB
Mod Pathol; 1992 Jul; 5(4):426-31. PubMed ID: 1495949
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
25. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
26. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
27. Metastatic HPV-related cervical adenocarcinomas presenting with thromboembolic events (Trousseau Syndrome): clinicopathologic characteristics of 2 cases.
Veras E; Srodon M; Neijstrom ES; Ronnett BM
Int J Gynecol Pathol; 2009 Mar; 28(2):134-9. PubMed ID: 19188822
[TBL] [Abstract][Full Text] [Related]
28. Unusual presentation of cervical cancer as advanced ovarian cancer.
Abdulhathi MB; Al-Salam S; Kassis A; Ghazal-Aswad S
Arch Gynecol Obstet; 2007 Oct; 276(4):387-90. PubMed ID: 17440746
[TBL] [Abstract][Full Text] [Related]
29. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
30. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
31. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
Ceballos KM; Shaw D; Daya D
Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
[TBL] [Abstract][Full Text] [Related]
32. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
34. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
35. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
36. High-grade primary peritoneal serous papillary carcinoma with a wide differential diagnosis: a diagnostic challenge.
Gilani S; Tashjian R; Fathallah L
Pathologica; 2012 Dec; 104(6):442-5. PubMed ID: 23547430
[TBL] [Abstract][Full Text] [Related]
37. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
Zhou C; Gilks CB; Hayes M; Clement PB
Am J Surg Pathol; 1998 Jan; 22(1):113-20. PubMed ID: 9422324
[TBL] [Abstract][Full Text] [Related]
38. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
39. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
[TBL] [Abstract][Full Text] [Related]
40. [Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
Tan YT; Zhang X; Lin ZQ; Chen Q; Wang LJ; Zhang BZ
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):120-3. PubMed ID: 18683751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
